Abstract:Background: Lipid metabolic alterations are emerging as significant mechanisms in the prognosis of cardiac remodeling induced by hypertension and could impact the therapies for cardiac fibrosis. The fatty acid transport/oxidation gene FABP4 acts as a metabolic and inflammation regulator, whose inhibition can attenuate kidney and renal interstitial fibrosis. However, its role in the heart remains unclear. Our study aimed to evaluate the density of FABP4 in patients and mouse model, and its association with cardiac fibrosis. Methods and Results: Single cell RNA sequencing of the heart and enriched Cd34-tdTomato + lineage cells in human and a murine model treated with angiotensin II were performed. Through the analysis of single-cell transcriptomes extracted from mouse hearts and human hearts tissues, we explored the transcriptomic landscape throughout cardiac fibrosis and revealed dysregulation of cardiac fibrosis, fatty acid transport/oxidation, and PPARγ signaling in the failing heart. We identified in which the FABP4 + fibroblasts were increased in diseased tissues accompanied by the accumulation of lipid droplets and cardiac fibrosis. Using pseudotime analysis, inducible lineage tracing and bone marrow transplantation models, our study showed that hypertension can expedite the differentiation of non-bone marrow-derived CD34 + cells into FABP4 + fibroblasts, leading to lipid accumulation and cardiac fibrosis. Furthermore, the PPARγ/Akt/Gsk3β pathway plays a critical role in orchestrating the differentiation process. Interestingly, both in vitro and in vivo, partial depletion of CD34 + cells using diphtheria toxin or pioglitazone treatment resulted in a notable reduction of FABP4 + fibroblasts and triglyceride in heart, along with an improvement in cardiac function through the PPARγ pathway. Additionally, GW9662, a selective antagonist of PPARγ, markedly reduced cell lipotoxicity and cardiac fibrosis. Conclusions: Collectively, our study provides valuable insights into the cellular landscape of the fibrotic heart with hypertension, indicating that the differentiation of non-bone marrow-derived CD34 + cells into FABP4 + fibroblasts accelerates the lipid accumulation and progression of cardiac fibrosis via PPARγ pathway.

FABP4 Enhances Lipidic and Fibrotic Cardiac Structural and Ca2+ Dynamic Changes

Possible involvement of fibrocytes in atrial fibrosis in patients with chronic atrial fibrillation.

Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes

Fatty-Acid-Binding Protein 4 as a Novel Contributor to Mononuclear Cell Activation and Endothelial Cell Dysfunction in Atherosclerosis

Abstract 4140979: CD34 + Cells Contributed to Cardiac Fibrosis Are Regulated by Hyperlipidemia

Pathophysiological role of fatty acid-binding protein 4 in Asian patients with heart failure and preserved ejection fraction

Altered lipid metabolism promoting cardiac fibrosis is mediated by CD34 + cell-derived FABP4 + fibroblasts

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPARα Pathway

FABP3 Deficiency Exacerbates Metabolic Derangement in Cardiac Hypertrophy and Heart Failure via PPAR Pathway

Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines

Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases

Local Production of Fatty Acid-Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis

Exogenous FABP4 interferes with differentiation, promotes lipolysis and inflammation in adipocytes

FABP3 deficiency exacerbates metabolic derangement in cardiac hypertrophy via PPARα pathway

CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

Epicardial adipocytes in the pathogenesis of atrial fibrillation: An update on basic and translational studies

Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation

Circulating adipocyte fatty acid-binding protein levels are independently associated with heart failure.

Association of free fatty acid binding protein with central aortic stiffness, myocardial dysfunction and preserved ejection fraction heart failure

Abstract 159: Endothelial Fatty Acid-binding Proteins Contribute to the Pathogenesis of Pulmonary Hypertension

Epicardial Adiposity in Relation to Metabolic Abnormality, Circulating Adipocyte FABP, and Preserved Ejection Fraction Heart Failure